Journal of Commercial Biotechnology — November 2010 issue now available

The November 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 16, Issue 4


For success in biotechnology, look beyond biotechnologyPDF
Yali Friedman


Federal bureaucrats slip on oil spillPDF
Henry I Miller


R&D spending and sources of funding of private US biopharmaceutical firms seeking to go publicPDF
David R Williams, Richard W Pouder
Algae and Biodiesel: Patenting energized as green goes commercialPDF
Matthew R Preiss, Stanley P Kowalski
Biotechnology industry-physician interaction and OIG guidelines: Evidence from the stock marketPDF
Thani Jambulingam, WaQar Ghani, Rajneesh Sharma
Exploratory assessment of the current EU regulatory framework for development of advanced therapiesPDF
Pawanbir Singh, Laure Brévignon-Dodin, Satya P Dash
Patenting of microorganisms: Systems and concernsPDF
Ramkumar Balachandra Nair, Pratap Chandran Ramachandranna

Legal and Regulatory Updates

Legal and Regulatory UpdatePDF
Gerry Kamstra
The aftermath of BilskiPDF
Thomas C Meyers, Adam M Schoen
Commentary regarding decision in Bilski from a biotech perspectivePDF
Thomas J Kowalski, Heidi E Lunasin, Deborah L Lu, Brian M McGuire, Frank J DeRosa

Book Reviews

Book Review: Biodesign: The process of innovating medical technologiesPDF
Randall Tagg, Catalina Bravo

Comments are closed.